Quercetin-6-C-β-d-glucopyranoside isolated from Ulmus wallichiana planchon is more potent than quercetin in inhibiting osteoclastogenesis and mitigating ovariectomy-induced bone loss in rats
Authors:
- Jawed A. SiddiquiJawed A. Siddiqui
- Kunal SharanKSKunal Sharan
- Gaurav SwarnkarGSGaurav Swarnkar
- Preeti RawatPRPreeti Rawat
- Manmeet KumarMKManmeet Kumar
- Lakshmi ManickavasagamLMLakshmi Manickavasagam
- Rakesh MauryaRMRakesh Maurya
- Dominique PierrozDPDominique Pierroz
- Naibedya ChattopadhyayNCNaibedya Chattopadhyay
- 1 February 2011
- journal article
- research article
- Published by Wolters Kluwer Health in Menopause
- Vol. 18 (2) , 198-207
Abstract
The aim of this study was to determine the skeletal effect of quercetin-6-C-β-D-glucopyranoside (QCG) isolated from the extract of Ulmus wallichiana and compare this effect with quercetin (Q) in a rat model of postmenopausal bone loss. Murine bone marrow cells were used to study the effect of QCG or Q on osteoclast differentiation. QCG or Q (1.0 and 5.0 mg kg(-1) d(-1) doses) was administered orally to ovarietomized (OVx) rats for 12 weeks. Sham-operated + vehicle and OVx + vehicle groups served as positive and negative controls, respectively. Bone mineral density, bone microarchitecture, biomechanical strength, bone turnover markers, and uterotrophic effect were studied. One-way analysis of variance was used to test significance of effects. QCG at 1.0 nM significantly inhibited differentiation of multinucleated osteoclasts and expression of osteoclastogenic genes from bone marrow cells, whereas Q at 10.0 μM had comparable results. OVx rats treated with QCG exhibited significantly higher bone mass and better microarchitecture in trabecular and cortical bones compared with OVx + vehicle. QCG treatment of OVx rats had better functional impact than did Q-treated OVx rats, evident from increased bone biomechanical strength. Serum osteocalcin and urinary fragments of type 1 collagen were significantly lower in QCG-treated OVx rats compared with OVx + vehicle group. The protective effect of QCG under ovariectomy-induced bone loss setting was found to be significantly better than Q. Uterine histomorphometry parameters of OVx rats did not change with QCG treatment. QCG improves bone biomechanical quality more effectively than Q through positive modifications of bone mineral density and bone microarchitecture without a hyperplastic effect on the uterus.Keywords
This publication has 34 references indexed in Scilit:
- Dietary quercetin inhibits bone loss without effect on the uterus in ovariectomized miceJournal of Bone and Mineral Metabolism, 2009
- Role of Phytochemicals in the Prevention of Menopausal Bone Loss: Evidence from In Vitro and In Vivo, Human Interventional and Pharmacokinetic StudiesCurrent Medicinal Chemistry, 2009
- Phyto-oestrogens and bone healthProceedings of the Nutrition Society, 2008
- Flavonoid quercetin decreases osteoclastic differentiation induced by RANKL via a mechanism involving NFκB and AP‐1Journal of Cellular Biochemistry, 2004
- Quercetin Suppresses Bone Resorption by Inhibiting the Differentiation and Activation of OsteoclastsBiological and Pharmaceutical Bulletin, 2004
- Potent inhibitory effect of naturally occurring flavonoids quercetin and kaempferol on in vitro osteoclastic bone resorptionBiochemical Pharmacology, 2003
- Phytoestrogens as hormone replacement therapy: an evidence-based approachPrimary Care Update for OB/GYNS, 2000
- Menopause and post-menopauseBailliere's Clinical Endocrinology and Metabolism, 1997
- Hormone therapy and phytoestrogensJournal of Clinical Pharmacy and Therapeutics, 1996
- THE LONG-TERM RISKS AND BENEFITS OF HORMONE REPLACEMENT THERAPYJournal of Clinical Pharmacy and Therapeutics, 1991